We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
PET | Wag Group Company | 0.40 | 0.1899 | 90.39% | 20,566,727 |
WORX | SCWorx Corporation | 1.27 | 0.29 | 29.59% | 769,777 |
GVH | Globavend Holdings Ltd | 0.8994 | 0.1894 | 26.68% | 446,721 |
CRKN | Crown Electrokinetics Corporation | 0.97 | 0.18432 | 23.46% | 5,370,810 |
WALD | Waldencast PLC | 3.84 | 0.43 | 12.61% | 22,809 |
PEV | Phoenix Motor Inc | 0.3766 | 0.0363 | 10.67% | 1,209,001 |
LGCL | Lucas GC Ltd | 1.10 | 0.101 | 10.11% | 2,711 |
SY | So Young International Inc | 0.9139 | 0.0839 | 10.11% | 129 |
NXTT | Next Technology Holding Inc | 2.20 | 0.20 | 10.00% | 3,695 |
PXLW | Pixelworks Inc | 0.7599 | 0.0588 | 8.39% | 10,309 |
HTOO | Fusion Fuel Green PLC | 0.339 | 0.024 | 7.62% | 31,406 |
NEW YORK, N.Y., Nov. 20, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) (the “Company”), a provider of data management services to healthcare providers, announced today that it has regained compliance with The Nasdaq Stock Market’s (“Nasdaq”) continued listing requirements regarding periodic reporting. On April 17, May 17, and August 19, 2024, Nasdaq notified the Company that it no longer met the Nasdaq’s periodic filing requirement under Listing Rule 5250(c)(1) (the “Rule”). In a letter dated October 14, 2024, Nasdaq indicated that based on the September 24, October 10, and October 11, 2024, filing of ...
BEIJING, Nov. 20, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the third quarter ended September 30, 2024.
– Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in near-term milestone payments and opt-in right for solid tumors – – Companies to jointly develop and commercialize ziftomenib; 50/50 profit share in the U.S.; Kura to lead U.S. development and commercial activities and book sales; Kyowa Kirin has exclusive commercialization rights outside the U.S. – – Companies to jointly pursue broad development program targeting acute leukemias, including frontline indications, combinations with targeted therapies and post-transplant maintenance setting – – Kura anticipates collaboration funding along with current cash balance to support AML program ...
Backblaze, Inc. (Nasdaq: BLZE), the cloud storage innovator providing a modern alternative to traditional cloud providers, today announced the launch of a proposed follow-on public offering of $30,000,000 of shares of its Class A common stock (the “Common Stock”). In addition, Backblaze expects to grant the underwriters a 30-day option to purchase up to an additional $4,500,000 of shares of Common Stock from Backblaze at the public offering price less the underwriting discount. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as ...
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 94,176.87 | 1,835.80 | 1.99% | 1.87T | 10,091,270,512 |
ETH | Ethereum | 3,079.49 | -30.62 | -0.98% | 372.02B | 3,563,413,411 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 119.66B | 1,026,959,285 |
SOL | Solana | 236.71 | -1.26 | -0.53% | 111.39B | 2,309,206,717 |
BNB | Binance Coin | 610.23 | -5.69 | -0.92% | 96.68B | 344,553,967 |
XRP | Ripple | 1.11 | 0.010 | 0.91% | 62.79B | 1,354,725,084 |
DOGE | Dogecoin | 0.37917 | -0.01191 | -3.05% | 55.54B | 3,095,680,415 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 35.56B | 1,780,671,867 |
STETH | stETH | 3,084.66 | -23.59 | -0.76% | 30.23B | 4,217,879 |
ADA | Cardano | 0.8128 | 0.0734 | 9.93% | 29.12B | 1,050,756,450 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions